Latent TB Infection and HIV? CDC Has Updated RecommendationsJuly 12, 2018 – CDCThe CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks for treatment of latent tuberculosis infection. The updated recommendations, published in CDC’s Morbidity and Mortality Weekly Report, support expanded use of an effective, shorter treatment regimen to reach even more people with latent TB infection, including people with HIV/AIDS... |
jueves, 12 de julio de 2018
Latent TB Infection and HIV? CDC Has Updated Recommendations | HIV.gov
Latent TB Infection and HIV? CDC Has Updated Recommendations | HIV.gov
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario